analyze sensitization characteristics of adult Chinese CRD patients and the value of allergy screening.
among office staff (68.9%) than among outdoor workers (42.8%, P < 0.05). Patients with COPD (42.9%) and recurrent exacerbation were atopic. Atopy was a risk factor for dyspnea (OR = 1.22; 95% CI, 0.95-1.75, P < 0.05). Optimal scaling analysis revealed a correlation between tIgE levels and smoking index (Cronbach`s alpha = 91.1%). In addition, the FVC levels in COPD patients with atopy were significantly lower than those without (2.06 L vs 2.63 L, P < 0.05). Up to 35.0% of patients who met the Global Initiative for Chronic Obstructive Lung Disease III (GOLD III) IV criteria and had a low Phadiatop level (≤10 kU/L), had a high tIgE level (≥1000 kU/L), compared to GOLD I II patients (5.5%).
Conclusion:
Patients with CRD had high sensitization. Asthma patients who work indoors were more susceptible to allergies. Atopy was associated with COPD pulmonary function, and we did not exclude COPD patients with more sensitization to uncommon allergens. It is necessary to initially screen the sensitization situation of CRD patients, which can guide the treatment, management, and prevention of CRD. Methods: 539 patients diagnosed with COPD and classified as severe according to the GOLD (Global Initiative for chronic obstructive lung disease) guideline at National Cheng Kung University Medical Center were recruited between January 2006 and December 2016. We recorded all patient's pulmonary function and severe acute exacerbation history in the preceding one year. We verify the study cohort's survival status and date of death by linkage with Taiwan National Mortality Registry from Health and Welfare Data Science Center. We estimated survival function by KaplanMeier method, and applied a rolling extrapolation algorithm to extrapolate the lifetime survival function and estimated their life expectancy. We also simulated age-, calendar year-, and sex-matched referents from national life tables to estimate the life expectancy, had the patients not developed COPD. We conducted a cross sectional survey of quality of life with the EuroQol five-dimension (EQ-5D) questionnaire among 291 patients, of which kernel smoothing mean is calculated and multiplied with lifetime survival function to obtain QALE(quality-adjusted life expectancy).
Results: There was no loss of LE for patients with mild COPD under GOLD definition. But those with moderate (80%>FEV1 ≥ 50% of prediction) and severe and very severe (FEV1<50% of prediction) COPD are associated with a shorter LE, or, 7.9 and 5.1 years, respectively, they also suffered from loss of life expectancy with EYLL of 7.6 and 10.7 years, respectively. The EYLL for those with severe acute exacerbation (AE) in the preceding one year is 10.0 years, which seems similar to those with severe and very severe stage. 
